Skip to Content

Publications

Cost-effectiveness of a decentralised molecular point-of-care testing programme for sexually transmitted infections in remote primary care health services in Australia

Sexually Transmitted Infections, 2026

Caroline G Watts, Louise M Causer, Susan J Matthews et al.

Access Cost-effectiveness of a decentralised molecular point-of-care testing programme for sexually transmitted infections in remote primary care health services in Australia publication
Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in Australia

Sexually Transmitted Infections, 2026

Annie Tangey, Kirsty Smith, Belinda Hengel et al.

Access Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in Australia publication

Decentralised COVID‐19 molecular point‐of‐care testing: lessons from implementing a primary care‐based network in remote Australian communities

Med J Aust 2025; 222 (4): 172-178. || doi: 10.5694/mja2.52589, 2025

Hengel B, Guy R, Casey D, Anderson L, Smith K, Andrewartha K, Applegate T, Saha A, Cunningham P, DeToca L, Rawlinson W, Martinello M, Tangey A, Patel P, Shephard M, Matthews S and Causer L.

Access Decentralised COVID‐19 molecular point‐of‐care testing: lessons from implementing a primary care‐based network in remote Australian communities publication
Understanding the role of patient communication protocols in sexually transmissible infections point-of-care testing among Aboriginal and Torres Strait Islander peoples in remote communities: a qualitative study

Sex Health. 2025 Feb:22:SH24214. doi: 10.1071/SH24214., 2025

Monaghan R, Causer L, Ward J, Hengel B, Smith K, Andrewartha K, Fairley C, Maher L, Mak D, White C, Leonard J, Guy R, Lafferty L, on behalf of the TTANGO Collaboration.

Access Understanding the role of patient communication protocols in sexually transmissible infections point-of-care testing among Aboriginal and Torres Strait Islander peoples in remote communities: a qualitative study publication
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia

Expert Review of Molecular Diagnostics, 24:12, 1125-1138. DOI: 10.1080/14737159.2024.2403091, 2024

Applegate TL, et al. On behalf of the Molecular POC Testing team and the National Aboriginal and Torres Strait Islander Health Protection AHPPP Subcommittee

Access Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia publication

External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles

Diagnostics 2024, 14(11), 1106, 2024

Matthews SJ, Miller K, Andrewartha K, Milic M, Byers D, Santosa P, Kaufer A, Causer LM, Hengel B, Gow I, Applegate T, Rawlinson WD, Guy R, Shephard M.

Access External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles publication

Flexible and Innovative Connectivity Solution to Support National Decentralized Infectious Diseases Point-of-Care Testing Programs in Primary Health Services: Descriptive Evaluation Study

J Med Internet Res 2023;25:e46701, 2023

Saha A, Andrewartha K, Badman SG, Tangey A, Smith KS, Sandler S, Ramsay S, Braund W, Manoj-Margison S, Matthews SJ, Shephard MD, Guy R, Causer LM.

Access Flexible and Innovative Connectivity Solution to Support National Decentralized Infectious Diseases Point-of-Care Testing Programs in Primary Health Services: Descriptive Evaluation Study publication

Roadmap to incorporating group A Streptococcus molecular point‐of‐care testing for remote Australia: a key activity to eliminate rheumatic heart disease

Med J Aust, 2022

Barth, D.D., Cinanni, G., Carapetis, J.R., Wyber, R., Causer, L., Watts, C., Hengel, B., Matthews, S., Ralph, A.P., Pickering, J., Cannon, J.W., Anderson, L., Wade, V., Guy, R.J. and Bowen, A.C.

Access Roadmap to incorporating group A Streptococcus molecular point‐of‐care testing for remote Australia: a key activity to eliminate rheumatic heart disease publication

A decentralised point-of-care testing model to address inequities in the COVID-19 response

Lancet Infect Dis 2021; 21: e183–90., 2021

Hengel B, Causer LM, Matthews S, Smith K, Andrewartha K, Badman S, Spaeth B, Tangey A, Cunningham P, Saha A, Phillips E, Ward J, Watts C, King J, Applegate T, Shephard M, Guy R.

Access A decentralised point-of-care testing model to address inequities in the COVID-19 response publication
Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators.

Implement Sci Commun 2, 127, 2021

Lafferty, L., Smith, K., Causer, L., Andrewartha, K., Whiley, D., Badman, S. G., Donovan, B., Anderson, L., Tangey, A., Mak, D., Maher, L., Shephard, M., Guy, R.

Access Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators. publication

A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing.

Pathology 2018;50: 317-321., 2018

Badman SG, Causer LM, Guy R, Wand H, Donovan B, Tabrizi S, Speers D, Shephard MD, Vallely A, Whiley D on behalf of the TTANGO investigators.

Access A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing. publication
Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.

Lancet Infect Dis. 2018 Oct;18(10):1117-1126., 2018

Guy RJ, Ward J, Causer LM, Natoli L, Badman SG, Tangey A, Hengel B, Wand H, Whiley D, Tabrizi SN, Shephard M, Fairley CK, Donovan B, Anderson DA, Regan DG, Maher L, Kaldor JM.

Access Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial. publication
Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation.

Sexually Transmitted Infections 2018;94:340-345., 2018

Causer LM, Guy RJ, Tabrizi SN, Whiley D, Speers D, Ward J, Tangey A, Badman SG, Hengel B, Natoli L, Anderson DA, Wand H, Wilson D, Regan DG, Shephard M, Donovan B, Fairley CK, Kaldor JM.

Access Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation. publication

A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis.

Sexually Transmitted Infections 2016; 92: 350-352., 2016

Badman SG, Causer LM, Guy R, Tabrizi S, Francis F, Donovan B, Whiley D on behalf of the TTANGO Investigators (including Shephard M).

Access A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis. publication

A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.

PLoS ONE 2015; 10(12): e0145993., 2015

Natoli L, Guy RJ, Shephard M, Causer L, Badman SG, Hengel B, et al.

Access A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting. publication
Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used?

Sexual Health; 12: 51-58, 2015

Natoli L, Guy RJ, Shephard M, Donovan B, Fairley C, Ward J, Regan D, Hengel B, Maher L on behalf of the TTANGO Investigators.

Access Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used? publication
Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.

BMJOpen; 5:e006922., 2015

Natoli L, Guy RJ, Shephard M, Whiley D, Tabrizi SN, Ward J, Regan DG, Badman SG, Anderson DA, Kaldor J, Maher L on behalf of the TTANGO investigator group.

Access Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. publication

A field evaluation of a new molecular-based point-of-care test for chlamydia and gonorrhoea in remote Aboriginal health services in Australia

Sex Health (2015) 12 (1): 27–33., 2014

Louise Causer, Belinda Hengel, Lisa Natoli, Annie Tangey, Steven Badman, Sepehr Tabrizi, David Whiley, James Ward, John Kaldor, Rebecca Guy and on behalf of the TTANGO investigators

Access A field evaluation of a new molecular-based point-of-care test for chlamydia and gonorrhoea in remote Aboriginal health services in Australia publication
Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.

PLoS ONE 2014; 9(6): e100518., 2014

Natoli L, Maher L, Shephard M, Hengel B, Tangey A, Badman S, Ward J, Guy R on behalf of the TTANGO investigators.

Access Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice. publication

A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol.

BMC Infectious Diseases 2013; 13: 485., 2013

Guy R, Natoli l, Ward J, Causer L, Hengel B, Whiley D, Tabrizi S, Donovan B, Fairley C, Badman S, Tangey A, Wand H, Shephard M, Regan D, Wilson D, Anderson D, Kaldor J.

Access A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol. publication
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.

Journal of Clinical Microbiology 2013; 51: 1945-1947., 2013

Tabrizi S, Unemo M, Golparian D, Twin J, Limnios A, Lahra M, Guy R, Ward J, Kaldor J, Donovan B, Wilson D, Wand H, Regan, D, Causer L, Hengel B, Natoli L, Anderson D, Whiley D, Shephard M, Fairley, C.

Access Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. publication